N-terminally truncated HER-2/neu protein as a cancer prognostic indicator
A Standard patent application filed on 13 November 1999 credited to Clinton, Gail

Details

Application number :

16246  

Application type :

Standard  

Application status :

CEASED  

Under opposition :

No  

Proceeding type :

 

Invention title :

N-terminally truncated HER-2/neu protein as a cancer prognostic indicator  

Inventor :

Clinton, Gail  

Agent name :

Davies Collison Cave  

Address for service :

Level 15 1 Nicholson Street MELBOURNE VIC 3000  

Filing date :

13 November 1999  

Associated companies :

 

Applicant name :

Oregon Health and Science University  

Applicant address :

Mail Code AD120, 22525 SW First Avenue, Suite 120, Portland, OR 97201, United States Of America  

Old name :

Oregon Health Sciences University  

Original Source :

Go  

Same Inventor

• Cartridge and pump with axial loading
• Detection of a characteristic antigen from carcinoma in body fluids
• HER-2 binding antagonists